Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

STAAR Surgical to Participate in Upcoming Investor Conferences


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that management will participate in several upcoming investor conferences. The Company has issued an updated investor presentation it will use during the upcoming meetings, which is available on the Company’s investor website at investors.staar.com.

Caren Mason, President & CEO, and Patrick F. Williams, CFO, will participate in the following investor conferences during the month of September:

  • William Blair West Coast Field Trip 2020, Wednesday, September 2
  • Wells Fargo 2020 Virtual Healthcare Conference, Wednesday, September 9
  • Morgan Stanley 18th Annual Global Healthcare Conference, Monday, September 14
  • Sidoti & Co. Small Cap Virtual Investor Conference, Thursday, September 24

Attendance at the investor conferences is by invitation only from each sponsoring research brokerage firm. Please contact the brokerage firm directly for more information.

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery is called an Implantable Collamer® Lens or “ICL”, which includes the EVO Visian ICL™ product line. More than 1,000,000 Visian® ICLs have been implanted to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: www.discovericl.com. Headquartered in Lake Forest, CA, the company operates manufacturing and packaging facilities in Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland. For more information, please visit the Company’s website at www.staar.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200902005311/en/

Staar Surgical Co. Aktie

37,05 €
-3,38 %
Einen Verlust von -3,38 % verzeichnet heute die Staar Surgical Co. Aktie.
Durchaus positiv bewertet unsere Community derzeit Staar Surgical Co. mit 14 Buy-Einschätzungen und 1 Sell-Einschätzungen.
Ein Kursziel von 48 € für Staar Surgical Co. würde eine Steigerung von mehr als 20% gegenüber dem aktuellen Kurs von 37.05 € bedeuten.
Like: 0
Teilen
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.

Rechtlicher Hinweis

Kommentare